(Reuters) – Cigna Corp (NYSE:) on Friday raised its forecasts for full-year profit and revenue and reiterated that it anticipates a negative earnings impact of about $1.25 per share this year from COVID-19.
Cigna’s rivals UnitedHealth (NYSE:) and Anthem Inc last month raised their adjusted profit targets for the year, signaling confidence in their business despite continued uncertainty related to the pandemic.
For the first-quarter, Cigna reported a nearly 2% fall in profit, hurt partly by higher costs related to COVID-19 testing, treatment and vaccines.
The company’s medical care ratio, the amount spent on medical claims versus the income from premiums, worsened to 81.8% in the quarter from 78.3% a year earlier.
Five analysts polled by Refinitiv had pegged the medical care ratio at 82.8%.
The health insurer said shareholders’ net income fell to $1.16 billion in the first quarter ended March 31 from $1.18 billion a year earlier. Shareholders’ net income per share rose to $3.30 from $3.15.
The company said it repurchased 12.7 million shares, through the end of the first quarter.
Cigna said it expects adjusted income from operations of at least $20.20 per share for 2021, up from its previous forecast of $20 per share, and adjusted revenue of at least $166 billion, up from at least $165 billion forecast earlier.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Be the first to comment